Categories Earnings, Technology
Automatic Data Processing (ADP) Q2 earnings tops estimates; raises outlook
Payroll processing firm Automatic Data Processing (NASDAQ: ADP) reported better-than-expected results for the Q2 2019 period aided by the ongoing transformation efforts and operational improvement initiatives.
ADP’s top line saw 8% improvement touching $3.5 billion helped by broad-based growth from all its divisions. Earnings saw a 17% drop due to one-time tax benefits recorded last year. However, adjusted earnings jumped 30% to $1.34 per share due to the transformation strategies started yielding results, along with the reduction in share count.
The company’s results topped street estimates on revenue and earnings front. For the second quarter, analysts were expecting earnings of $1.18 per share on sales of $3.44 billion. Last year, the company reported EPS of $0.99 on sales of $3.24 billion.
Segment Update
Revenue from the Employer Services side rose 7% as new business bookings saw modest growth of 1%. However, profits jumped 26% over last year due to improved margins. PEO Services revenue grew 12% driven by 9% growth in average worksite employees serviced by the division.
Going Forward
ADP has lifted its outlook for fiscal 2019 period backed by strong growth expected to be reported from all its segments. The company expects revenue to improve 6% to 7% while adjusted earnings to see a growth of 17% to 19%, an increase from 15% to 17% range outlook provided earlier.
On the segment front, the HRO firm is confident of expanding its client base. New business bookings from the Employer Services division is expected to see a growth of 6% to 8% and client retention to improve 25 to 50 basis points.
On the PEO front, average worksite growth of employees to see 8% to 9% improvement, but margins are expected to remain flat. ADP has factored in the Celergo acquisition and other foreign currency impacts into the 2019 outlook.
Related: ADP Q1 2019 Earnings Call Transcript
ADP’s share price increased above 2% trading at $137.5 levels during the pre-market trading session post the earnings announcement. The company saw an 11% improvement in share price over the last 12 months touching a new 52-week high of $153.51 in October 2018.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on